Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Riboflavin and Amitriptyline in Migraine Attack
IRCT20230823059240N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of riboflavin and amitriptyline in migraine, sponsored by Qazvin University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
riboflavinamitriptyline
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20230823059240N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230823059240N1.